— Know what they know.
/
Not Investment Advice

BDSI NASDAQ

BioDelivery Sciences International, Inc.
1W: +0.0% 1M: +0.5% 3M: +81.5% 1Y: +49.5% 3Y: +10.9% 5Y: +197.3%
$5.59
Last traded 2022-03-31 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $577.1M mcap
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Supply Chain Overview

1 relationships
0
As Filer
counterparties named
1
As Counterparty
mentioned by others
2022-02-14
Earliest Filing
2022-02-14
Latest Filing

Mentioned As Counterparty

1 mentions

Other companies that named BDSI in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
COLL COLLEGIUM PHARMACEUTICAL, INC acquirer Target company whose common stock is the subject of the cash tender offer and subsequent merger. 2022-02-14 View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms